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Abstract
The barrier function of the skin protects the mammalian body against infection, dehydration, UV irradiation and
temperature fluctuation. Barrier function is reduced with the skin’s intrinsic aging process, however the molecular
mechanisms involved are unknown. We previously demonstrated that Claudin (Cldn)-containing tight junctions (TJs) are
essential in the development of the epidermis and that transgenic mice overexpressing Cldn6 in the suprabasal layers of the
epidermis undergo a perturbed terminal differentiation program characterized in part by reduced barrier function. To
dissect further the mechanisms by which Cldn6 acts during epithelial differentiation, we overexpressed a Cldn6 cytoplasmic
tail deletion mutant in the suprabasal compartment of the transgenic mouse epidermis. Although there were no gross
phenotypic abnormalities at birth, subtle epidermal anomalies were present that disappeared by one month of age,
indicative of a robust injury response. However, with aging, epidermal changes with eventual chronic dermatitis appeared
with a concomitant barrier dysfunction manifested in increased trans-epidermal water loss. Immunohistochemical analysis
revealed aberrant suprabasal Cldn localization with marked down-regulation of Cldn1. Both the proliferative and terminal
differentiation compartments were perturbed as evidenced by mislocalization of multiple epidermal markers. These results
suggest that the normally robust injury response mechanism of the epidermis is lost in the aging Involucrin-Cldn6-CD196
transgenic epidermis, and provide a model for evaluation of aging-related skin changes.
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Introduction
Formed during development by a series of cell commitment,
mesenchymal-epithelial cell interactions, and terminal differentia-
tion, the mammalian epidermis undergoes continuous self-renewal
in a tightly regulated process of epidermal cell proliferation and
differentiation [1–3]. As the end result of terminal differentiation,
the robust barrier function of the skin protects against microorgan-
ism invasion and UV irradiation, inhibits water loss, regulates body
temperature and is an important part of the host defense system [4].
These important functions decline in efficiency with aging, leading
to an inefficient epidermal injury response and dermatitis [5–7], for
reasons that are not yet understood.
Tight junctions (TJs) are essential not only for dividing epidermal
cells into apical and basolateral compartments to create cell polarity
[8], but also for the existence of skin barrier function by regulating
the selective permeability of the paracellular pathway [9–11]. The
selectivity function of TJs is imparted by Claudins (Cldns), a family
of 23 highly conserved tetraspan membrane proteins whose
heterogeneity stems in large part from distinctly charged amino
acid sequences in the first external loop [11–13]. Cldn type and
mixing ratio thus provide for the specific permeability requirements
of different epithelia [12]. The importance of Cldns in epidermal
differentiation and barrier function has been confirmed by
experiments in which Cldn expression has been perturbed in
epidermal cells; for example, Cldn1 knockout mice die shortly after
birth due to skin barrier dysfunction [14]. Involucrin-Cldn6 (Inv-
Cldn6) transgenic mice also suffer skin barrier dysfunction, the
severity/lethality of which is dependent upon the level of Cldn6
overexpression [15,16]. Further, Inv-Cldn6-CD187 transgenic mice
overexpressing a cytoplasmic tail-ablated Cldn6 display epidermal
hyperproliferation,apparentlyduetoaninefficiencyofCldn protein
membrane targeting, as a result of the unfolded protein response
pathway [17].
The latter data suggest the importance of the cytoplasmic tail
portion of Cldn molecules in cell signaling during epidermal
differentiation. The cytoplasmic tail of different Cldns, while
relatively constant in length, is divergent in sequence, but a
number of putative functional protein domains are present in
many family members [12,18]. To address the activities of the
functional domains in more detail, we again used the involucrin
promoter (Inv) this time to target a shorter deletion in the
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of the epidermis. The Inv-Cldn6-CD196 transgenic mice possess
subtle epidermal differentiation abnormalities at birth that by
1-month of age are completely normalized. However, with aging,
Inv-Cldn6-CD196 mice suffered dermatitis, often manifested as
patent wounds in repetitive grooming areas. Normal hydration
levels were not maintained in the aging skin, and immunohisto-
chemistry revealed perturbations in the expression and localization
of multiple Cldns, as well as various classical markers of epidermal
differentiation. These results suggest that the normally robust
injury response mechanism of the epidermis is lost in the aging
Inv-Cldn6-CD196 transgenic epidermis and provides a model for
evaluation of chronic dermatitis and aging-related skin changes.
Methods
Generation of Inv-Cldn6-CD196 transgenic mice
The Inv-Cldn6-CD196 construct [19] was injected into ova
collected from superovulated CD1 mice to generate viable lines at
the Ottawa Hospital Research Institute (OHRI) Transgenic
Mouse Facility as previously described [20]. Genotyping was
performed by PCR using genomic DNA and primers specific for
Cldn6 (59-ATG GCC TCT ACT GGT CTG CA-39) and the
FLAGH tag (59-TCA CTT GTC ATC GTC GTC CTT G-39).
Age-matched wild type and Inv-Cldn6-CD196 transgenic mice
were photographed using a Nikon COOL-PIX950 digital camera
(Nikon) for image processing with Adobe Photoshop version 7.0
(Adobe Systems). All research complied with the principles and
guidelines of the Canadian Council on Animal Care and was
approved by the Ottawa Hospital Research Institute Animal Care
Committee. Once the dermatitis phenotype became unmanage-
able, Inv-Cldn6-CD196 transgenic mice were euthanized accord-
ing to institutional and legislative policies.
Sample preparation, histology and
immunohistochemistry
a) Sample collection. Freshly dissected skin samples
(,1c m
2) were collected at various postnatal time points (birth, 1
week, 2 weeks, 3 weeks, 1 month, 2 months, 3 months, 5 months, 6
months) from either the mid-dorsal region or areas of frequent
grooming (e.g. the neck and behind the ears) of Inv-Cldn6-CD196
transgenic mice and their age-matched CD1 counterparts.
b) Frozen sections. Frozen sections were required for
immunolocalization with FLAGH antibodies, whereas histology
and all other immunostaining procedures were performed using
paraffin-embedded sections. For frozen sections, skin samples
were embedded in HistoPrep (Fisher Scientific), solidified using
dry ice-chilled isopentane and 5 mm sections were mounted
onto SuperfrostH/Plus slides (Fisher Scientific) as described [17].
Samples were fixed for 10 minutes in methanol (220uC) and
washed with PBS before immunohistochemistry (see below).
c) Paraffin sections and histology. For paraffin sections,
skin samples were fixed overnight in Bouin’s solution (75%
saturated picric acid, 20% formaldehyde, 5% glacial acetic acid)
and dehydrated via a graded series of ethanol washes (from 30% to
100%) before paraffin embedding and sectioning (5 mm). Sections
mounted onto SuperfrostH/Plus slides (Fisher Scientific) were
dewaxed using toluene and rehydrated in a reverse graded series of
ethanol washes to water. Following antigen unmasking and
washing in PBS, sections were either stained with hematoxylin
and eosin (H&E) as described [15] or further processed for
immunohistochemistry (see below).
d) Immunohistochemistry. After blocking for non-specific
antibody binding (10% goat serum, 0.8% BSA, 1% gelatin in
PBS), skin samples were incubated for 1 hour in antibodies
appropriately diluted in incubation buffer (1% goat serum, 0.8%
BSA, 1% gelatin in PBS) [15]. Antibodies recognizing the
following proteins were used: FLAG
H (M2 monoclonal) (1:440;
Sigma), K15 (1:100; rabbit #UC55), K5 (1:100; rabbit #5054),
K14 (1:100; rabbit #199), K1 (1:100; rabbit #UC81), K6 (1:200;
BabCO), K17 (1:500; a gift from Dr. Pierre Coulombe, Johns
Hopkins), involucrin (1:100; BabCO), filaggrin (1:100; BabCO),
loricrin (1:100; rabbit #UC84), Cldn1 (6:100; Zymed
Laboratories), Cldn2 (1:200; Zymed Laboratories), Cldn3 (1:50;
Zymed Laboratories), Cldn5 (1:100; Zymed Laboratories), Cldn6
(1:100; hen #3677), Cldn11 (1:100; hen #3680), Cldn12 (1:100;
hen #5186) and Cldn18 (1:100; rabbit #A9953). Following
washes (0.8% BSA, 1% gelatin in PBS), skin samples were
incubated for 1 hour at room temperature with FITC-conjugated
secondary antibodies against mouse, rabbit and chicken (1:50;
Jackson ImmunoResearch) diluted in incubation buffer. After
washes in wash buffer and PBS, sections were mounted with
Moviol 4–88 (Calbiochem) containing 2.5% 1,4 diazobicyclo-
[2,2,2]-octane (DABCO; Sigma) for observation on a Zeiss
Axioplan 2 fluorescence microscope equipped with an AxioCam
camera and Axio Vision 2.05 software (Carl Zeiss); digital images
were processed using Adobe Photoshop version 7.0 (Adobe
Systems).
Protein isolation and immunoblotting
Skin samples (0.4 g) were dissected from either the mid-dorsal
region or areas of frequent grooming (e.g. the neck and behind the
ears) of Inv-Cldn6-CD196 transgenic mice and their age-matched
CD1 counterparts and whole cell protein extracts were prepared by
homogenizing in SDS extraction buffer (62.5 mM Tris pH 6.8,
25%glycerol,2%SDSand2%b-mercaptoethanolwithpepstatinA
and a complete mini protease inhibitor cocktail tablet [Roche])
followed by centrifugation. Following a 30-minute incubation in
sample reducing buffer (62.5 mM Tris pH 6.8, 25% glycerol, 2%
SDS, 0.1% bromophenol blue and 2% b-mercaptoethanol), boiling
and centrifugation, 10 mg of soluble proteins were separated on
12% SDS-polyacrylamide gels and transferred to nitrocellulose
[17]. After blocking for non-specific antibody binding (5% skim
milk, TBS/0.1% tween-20 [TBS-T]), blots were incubated at 4uC
overnight with diluted (5% skim milk, TBS-T) antibodies against
FLAGH (polyclonal)(1:500;Sigma)and GAPDH (1:20,000;Abcam).
After several washes in TBS-T, blots were incubated in diluted
(5% skim milk, TBS-T) HRP-conjugated antibodies against mouse
and rabbit IgG (1:20,000; Amersham) for 1 hour at room
temperature and washed with TBS-T before incubation with
chemiluminescent HRP substrate (Millipore) and visualization on
BioMax XAR autoradiography film (Kodak). Films were scanned
and digital images were prepared using Adobe Photoshop version
7.0 (Adobe Systems).
Barrier integrity assay
Trans-epidermal water loss (e.g. impedence) of both Inv-Cldn6-
CD196 transgenic and wild type mouse skin was measured using a
dermal phase meter (DPM) (Nova Technology Corporation) as
described [16]. Diminished barrier integrity is reflected in higher
DPM values over time as depicted digitally with EDWINA
software (Nova Technology Corporation) and converted into
graphical form with Excel software (Microsoft).
Cornified envelope extracts
Using dorsal skin samples of CD1 and Inv-Cldn6-CD196
transgenic mice, purified cornified envelope extracts were
prepared as described [16,21,22]. Briefly, skin samples were
Aging Related Skin Phenotype
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SDS, 20 mM dithiothreitol, 5 mM EDTA), followed by 15-minute
incubation at 95uC and gentle centrifugation before observation
using an Olympus CK2 inverted microscope (Olympus) equipped
with a Nikon COOLPIX 4500 digital camera (Nikon). Images were
produced with Adobe Photoshop version 7.0 (Adobe Systems).
Results
Generation and expression analysis of Inv-Cldn6-CD196
transgenic mice
We previously reported that overexpression of a Cldn6 lacking
the C-terminal half of the cytoplasmic tail domain (e.g. truncation
after amino acid 196; Cldn6-CD196) (Figure 1A-C) in the
suprabasal compartment of the mouse epidermis results in marked
hyperproliferative squamous invaginations/cysts replacing hair
follicles and lethal epidermal barrier dysfunction [19]. The
rationale for generating the D196 mutation was based on two
main factors. First, we already knew that tailless Cldn6 was not
targeting to the membrane appropriately. Second, we wanted to
delete the PDZ domain that is at the tip of the cytoplasmic tail as
well as putative phosphorylation sites, which could be accom-
plished by deletion from amino acid 196. The choice of 196 rather
than 195 or 197, both of which would also have accomplished
removal of the PDZ and putative phosphorylation sites, was one of
convenience for the steps required to make our mutant insert.
Because we have demonstrated previously that the level of Cldn6
overexpression correlates to the severity of the phenotype [15,16],
we re-derived F0s with lower Cldn6-CD196 expression to avoid
lethality and explore the function of the Cldn6 tail in postnatal
animals; levels of expression of the mutant Cldn6 is half of that
observed in our previously generated mice. Nine Inv-Cldn6-
CD196 positive F0 transgenic mice (five females and four males)
were generated and three viable lines exhibiting indistinguishable
phenotypes were successfully established. Cldn6-CD196 expres-
sion was confirmed to be confined to the upper spinous and
granular layers of the epidermis and localized to cell membranes,
mimicking endogenous Cldn6 expression (Figure 1D). Immuno-
blotting confirmed a ,19.5kDa band corresponding to the
transgene product in skin samples from Inv-Cldn6-CD196 but
not wild type littermates (Figure 1E).
Inv-Cldn6-CD196 neonates displayed no gross phenotypic
anomalies compared to theirwildtype counterparts;trans-epidermal
water loss (TEWL) measurements (DPM in the range of 98–105)
Figure 1. Inv-Cldn6-CD196 transgenic mice. The Cldn6 protein
sequence is shown; transmembrane-spanning regions are encased
within boxes, the CXXC motifs are underlined, and the truncation site is
indicated with an arrow (A). The Inv-Cldn6-CD196 mutant was created
by deleting the C-terminal half of the cytoplasmic tail domain of Cldn6
after amino acid 196 (B). The Inv promoter was use to drive transgene
expression to the suprabasal compartment of the transgenic mouse
epidermis, where TJs are localized (C). Transgene expression was
confirmed to be restricted to the upper spinous and granular layers of
the epidermis as visualized by immunohistochemistry using anti-FLAG
antibodies (D) and immunoblotting confirmed a ,19.5kDa band
corresponding to the transgene product in skin samples from
transgenic (TG) but not wild type (WT) skin samples using anti-GAPDH
as a loading control (E). Trans-epidermal water loss measurements
confirmed no skin barrier dysfunction in the Inv-Cldn6-CD196
transgenic mice at birth (F). This was further supported by evaluation
of cornified envelopes; which were characterized by a rigid shape and
uniform size comparable to that of the wild type (G). Inv-Cldn6-CD196
mice were easily identifiable by their frizzed and lackluster coat
appearance as compared to the wild type, a phenotype that persisted
throughout life (H).
doi:10.1371/journal.pone.0007814.g001
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b-D-galactopyranoside) penetration (not shown) confirmed no skin
barrier dysfunction in the transgenic mice at birth. Extracts from
Inv-Cldn6-CD196 mouse skin revealed normal looking cornified
envelopes, with a rigid shape and uniform size (Figure 1G), pro-
viding further evidence that early postnatal barrier function was not
perturbed. As was observed inourInv-Cldn6 and Inv-Cldn6-CD187
mouse models [15,23], however, the emergence of hair fibers
provided a diagnostic identifier for Inv-Cldn6-CD196 transgenic
mice. In comparison to the sleek and lustrous appearance of wild
type mice, the coat of Inv-Cldn6-CD196 mice was frizzed and
lackluster, a phenotype that persisted throughout life (Figure 1H);
however since it does not appear to have any direct relevance to the
aging-related skin barrier defects reported herein, it has not been
further explored.
Epidermal maturation is delayed in Inv-Cldn6-CD196
mice
Although in the epidermis there were no gross phenotypic
abnormalities or barrier dysfunction apparent at birth, histological
examination revealed that the newborn (Figure 2A) and 1 week-
old (not shown) transgenic epidermis was moderately thicker than
that of the wild type, with a thicker stratum corneum, a less-
compacted granular layer and an overall expanded suprabasal
compartment. By 2-weeks of age, the Inv-Cldn6-CD196 epidermis
displayed a more compact and organized granular layer, but it
remained less mature and thicker than that in the wild type
animals (Figure 2B). Typical epidermal thinning had commenced
in the transgenic epidermis by 3-weeks of age (,1 week later than
wild type; not shown) and by 1-month of age the Inv-Cldn6-
CD196 transgenic epidermis was histologically indistinguishable
from that of the wild type (Figure 2C).
Consistent with the histological results, abnormalities in the
expression of epidermal differentiation markers were present in
neonatal Inv-Cldn6-CD196 mice but these also normalized by 1-
monthofage(Figure 3;thetransgenicandwildtype epidermisafter
2 weeks and 1 month are shown). For example, K5 and K15 were
restricted to basal cells at all time points in both the wild type and
Inv-Cldn6-CD196 epidermis (not shown), but K14, another basal
compartment marker, occupied an expanded zone extending into
the suprabasal compartment at birth and until epidermal thinning
was achieved in the Inv-Cldn6-CD196 epidermis (Figure 3A). The
suprabasal layers of the epidermis normally express K1 [24], and
when in a state of hyperproliferation, K6 and K17 [25–27]. While
neither K6 nor K17 was expressed throughout the time analyzed
(not shown), a broadened compartment of K1-positive cells,
consistent with the increased number of suprabasal cell layers
observed histologically,wasseenearly but normalized by1-month of
age in the Inv-Cldn6-CD196 transgenic epidermis (Figure 3B).
Similarly the expression compartments of various structural proteins
in the stratum corneum, including involucrin (Figure 3C), filaggrin
and loricrin (not shown), were also expanded in the juvenile Inv-
Cldn6-CD196 epidermis, and a tightly compacted stratum corneum
was not observed in the transgenic epidermis until thinning
comparable to that in the wild type was achieved.
In parallel with changes in epidermal markers, the thickened
newborn and 1-week-old Inv-Cldn6-CD196 epidermal basal layer
was devoid of Cldn1, which was clearly present in the wild type
epidermis (not shown). However, after 2 weeks, sporadic Cldn1-
positive basal cells were evident, and the frequency increased as
thinning progressed until 1-month of age when Cldn1-positive
cells completely occupied the basal and suprabasal compartments
in both the transgenic and wild type mice (Figure 3D). The
suprabasal-specific Cldns, Cldn6 (Figure 3E), Cldn11, Cldn12
and Cldn18 (not shown) were seen in the expanded suprabasal
region of the Inv-Cldn6-CD196 epidermis; each Cldn evaluated
maintained a strictly membranous localization and normalized by
1-month to a zone comparable to wild type. Cldns that are not
normally expressed in the epidermis (e.g. Cldn2, Cldn3 and
Cldn5) [16] were not observed in either the wild type or Inv-
Cldn6-CD196 epidermis at any time evaluated (not shown). The
data suggest that Inv-Cldn6-CD196 transgenic mice are born with
differentiation abnormalities leading to slower epidermal matura-
tion, but these are too mild to manifest in skin barrier defects or
death, and are repaired between birth and 1-month of age.
Inv-Cldn6-CD196 mice experience age-related
perturbations in epidermal differentiation and injury
repair resulting in chronic dermatitis
Although by 1-month of age the Inv-Cldn6-CD196 epidermis
was morphologically and biochemically indistinguishable from the
Figure 2. Histological abnormalities in the Inv-Cldn6-CD196
transgenic epidermis. Histological analysis of newborn (A) Inv-
Cldn6-CD196 transgenic mice as compared to the wild type revealed a
moderately thicker epidermis in transgenic samples, with a thicker
stratum corneum, a less-compacted granular layer and an overall
expanded suprabasal compartment. At 2-weeks of age (B), the Inv-
Cldn6-CD196 epidermis remained somewhat less mature and thicker
than that of the wild type; however by 1-month of age (C) the
transgenic and wild type samples were histologically indistinguishable.
doi:10.1371/journal.pone.0007814.g002
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shown) of age, the transgenic epidermis showed histological
evidence of thickening that persisted, and was somewhat
exacerbated, at 3 (Figure 4A) and 6 (Figure 4B) months. At
the latter ages, an expanded stratum corneum, increased number
of suprabasal/spinous cell layers and a less compacted granular
layer were clearly present, and reminiscent of the 2-week-old Inv-
Cldn6-CD196 epidermis (see above).
The histological results suggested that intrinsic changes
occurred in the transgenic epidermis, a possibility supported by
the perturbed expression of differentiation markers; because results
were similar from 2- to 6-months of age, we report results from 3-
month-old Inv-Cldn6-CD196 transgenic mice only (Figure 5).
K14 was expressed throughout the basal and suprabasal
compartments in the aging Inv-Cldn6-CD196 epidermis
(Figure 5A), while K5 (not shown) and K15 (Figure 5B)
remained restricted to basal cells as in the wild type epidermis. K1
(Figure 5C) was seen throughout an expanded suprabasal zone in
the transgenic epidermis corresponding to the increased number of
spinous cell layers; however, neither K6- (Figure 5D) nor K17-
positive (Figure 5E) interfollicular epidermal cells were observed
nor was there any up-regulation in the expression of Ki67 or CD3
(not shown), suggesting no detectable hyperproliferation or
immune cell infiltration. The localization of involucrin
(Figure 5F), loricrin (not shown) and filaggrin (Figure 5G)
suggested that there were also perturbations in terminal differen-
tiation in the aged Inv-Cldn6-CD196 epidermis, with each marker
occupying an expanded zone of expression consistent with the
abnormal morphological appearance of the stratum corneum
described above.
Cldn expression was also modified with striking anomalies
consistent with those we reported earlier in an acute irritant (12-O-
tetradecanoylphorbol-13-acetate (TPA))-induced epidermal injury
response [23]. The number of Cldn1-positive basal and suprabasal
Figure 3. Perturbation of markers of epidermal differentiation. Immunofluorescence was used to evaluate various markers of epidermal
differentiation including K14 (A), K1 (B), involucrin (C), Cldn1 (D) and Cldn6 (E) in Inv-Cldn6-CD196 mice as compared to their age-matched wild type
counterparts. In each case abnormalities were present in samples from 2-week old (left panel) transgenic mice that were normalized by 1-month of
age (right panel). For example, the K14 expression zone was extended into the suprabasal compartment the Inv-Cldn6-CD196 epidermis until
epidermal thinning was achieved. In addition, broadened K1 and involucrin expression compartments was seen early but normalized by 1-month of
age. Sporadic Cldn1-positive basal cells were evident in the 2-week old transgenic epidermis; by 1-month of age Cldn1-positive cells occupied both
the basal and suprabasal compartments reminiscent of the wild type. Cldn6, a suprabasal-specific Cldn, was observed in an expanded zone early on,
and was normalized by 1-month of age.
doi:10.1371/journal.pone.0007814.g003
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of Cldn6- (Figure 6B), Cldn11- (Figure 6C), Cldn12-
(Figure 6D) and Cldn18-positive cells (Figure 6E) was seen in
the transgenic epidermis; concomitantly, a shift away from a
strictly membrane localization was evident. Cldn2, Cldn3 and
Cldn5 were not expressed in either wild type or transgenic animals
(not shown).
Taken together, the data suggest an intrinsic propensity for
injury and inefficient repair that increases with aging in the Inv-
Cldn6-CD196 epidermis. This is further supported by two lines of
evidence. First, histological and biochemical changes resulting
from TPA treatment were seen earlier (4 hours versus 12 hours)
and repaired more slowly (no repair versus normalization by
96 hours) in Inv-Cldn6-CD196 versus wild type epidermis when
mice were tested at 1 month of age (data not shown). Second,
obvious signs of dermatitis, especially in areas subjected to
repetitive mechanical stress during grooming (e.g. the neck and
behind the ears), were seen in the aging Inv-Cldn6-CD196
epidermis (Figure 7A). Histological evaluation of skin samples
from these regions revealed a significantly thickened epidermis
with an increased number of spinous/suprabasal cell layers and
cellular disorganization; the upper differentiation layers were also
abnormal, with parakeratosis, the prevalent appearance of nuclei,
an improperly packed granular layer and a thicker stratum
corneum (Figure 7B). In the dermatitis-affected areas, K14
(Figure 5H) and K5 (not shown) were expressed in an expanded
zone far into the suprabasal compartment, and K15 expression
was only sporadically expressed (Figure 5I). K1 was localized
throughout the thickened suprabasal zone of the dermatitis-
affected Inv-Cldn6-CD196 epidermis, and staining appeared punc-
tate, suggesting a keratin filament bundling defect (Figure 5J).
K6 was seen consistently throughout the basal and suprabasal
layers of the dermatitis-affected epidermis (Figure 5K); K17-
positive basal and suprabasal cells were somewhat more spo-
radically seen (Figure 5L). Expression compartments for
involucrin (Figure 5M), loricrin (not shown) and filaggrin
(Figure 5N) were also expanded, with an obvious packing defect
reminiscent of the observed histological abnormalities of the
Figure 4. Histological evidence of epidermal abnormalities in
the aging Inv-Cldn6-CD196 transgenic epidermis. Histological
evidence of epidermal abnormalities emerged in aging Inv-Cldn6-
CD196 transgenic mice after 3 (A) and 6 (B) months as compared to the
wild type. These included an expanded stratum corneum, as well as an
expanded suprabasal zone and a less compacted granular layer
suggesting an intrinsic propensity for injury and inefficient repair that
increases with aging in the Inv-Cldn6-CD196 epidermis.
doi:10.1371/journal.pone.0007814.g004
Figure 5. Aberrance in markers of epidermal differentiation
during aging. Changes in the epidermal differentiation program of
the aging Inv-Cldn6-CD196 transgenic epidermis were evaluated by
immunofluorescence and compared to their age-matched wild type
counterparts (samples from 3-month-old mice are shown – left panel);
their expression/localization in dermatitis-affected areas is also indicat-
ed (right panel). K14 was expressed throughout the basal and
suprabasal compartments in the aging Inv-Cldn6-CD196 epidermis
(A), while K15 remained restricted to basal cells (B). The zone of K1
expression was expanded in the 3-month-old transgenic epidermis (C);
however, neither K6- (D) nor K17-positive (E) cells were observed. An
expanded zone of expression, and improper packing, of involucrin (F)
and filaggrin (G) suggested perturbations in terminal differentiation
program of the aged Inv-Cldn6-CD196 epidermis. In the dermatitis-
affected areas, K14 (H) expression was expanded far into the suprabasal
compartment, while K15 was only sporadically observed (I). A punctate
K1 localization was evident throughout the thickened suprabasal zone
of the dermatitis-affected Inv-Cldn6-CD196 epidermis (J), and K6- (K)
and K17-positive (L) basal and suprabasal cells were observed. In
addition, involucrin (M) and filaggrin (N) expression compartments
were also expanded, with obvious packing defects evident.
doi:10.1371/journal.pone.0007814.g005
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PLoS ONE | www.plosone.org 6 November 2009 | Volume 4 | Issue 11 | e7814Figure 6. Evaluation of Cldns in the aging Inv-Cldn6-CD196 transgenic epidermis. The expression/localization of Cldns was also perturbed
in the aging Inv-Cldn6-CD196 transgenic epidermis (samples are from 3-month-old mice – left panel); the dermatitis-affected zones are also shown
(right panel). Cldn1-positive basal and suprabasal cells were reduced in the aging Inv-Cldn6-CD196 epidermis (A). In addition, a shift away from a
strictly membrane localization and an expanded zone of suprabasal Cldns was evident - Cldn6 (B), Cldn11 (C), Cldn12 (D) and Cldn18 (E). These
abnormalities in were strikingly exacerbated in the dermatitis-affected epidermis. For instance, the basal and lower suprabasal layers were void of
Cldn1 localization (F). In addition, Cldn6 (G), Cldn11 (H), Cldn12 (I) and Cldn18 (J) localization was observed throughout the expanded suprabasal
zone with membranous localization less evident in the lower suprabasal layers.
doi:10.1371/journal.pone.0007814.g006
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Cldn12 and Cldn18 localization observed in the aged Inv-
Cldn6-CD196 transgenic epidermis (see above) were strikingly
exacerbated in the dermatitis-affected epidermis. Cldn1 was
completely absent in the basal and lower suprabasal layers, but a
strictly membranous localization was preserved in the Cldn1-
positive upper suprabasal zone (Figure6F). While the distribution
of Cldn6 (Figure 6G), Cldn11 (Figure 6H), Cldn12 (Figure 6I)
and Cldn18 (Figure 6J) corresponded to the expanded suprabasal
compartment of the dermatitis-affected Inv-Cldn6-CD196 epider-
mis, immunostaining was less intense and membranous localiza-
tion less evident in lower suprabasal layers.
The morphological and biochemical abnormalities described
predict altered permeability barrier properties and potentially
barrier dysfunction in areas of repeated insult of the aged
Inv-Cldn6-CD196 transgenic epidermis. In keeping with this
hypothesis, TEWL measurements across the dermatitis-affected
transgenic skin increased ,8-fold (DPM in the range of 790–830
versus 95–100 of normal adult skin) (Figure 7C).
Discussion
In this study, we used transgenic mouse technology to expand
on our structure-function approach to elucidating the role of
the cytoplasmic tail of Cldn6 in epidermal development and
the formation and maintenance of skin barrier integrity. We
demonstrate that Inv-Cldn6-CD196 mice display epidermal
differentiation abnormalities at birth that result in slower
epidermal maturation but are apparently normalized by 1-month
of age. However, with aging, intrinsic properties of the Inv-Cldn6-
CD196 epidermis are manifested by a propensity for injury and
inefficient repair, eventually resulting in chronic dermatitis
especially in areas subjected to frequent insult via grooming.
Changes in Cldn expression and localization suggest marked
changes in the presence and function of TJs, as also evidenced by
skin barrier dysfunction. Taken together, our data suggest that the
overexpression of a Cldn tail truncation mutant in the suprabasal
compartment of the mouse epidermis results in its delayed
maturation, a propensity for injury, diminished repair and skin
barrier deficiency reminiscent of the intrinsic aging process of
human skin.
It is well established that the formation of the epidermal per-
meability barrier (EPB) is developmentally regulated [16,28–30]
and that disruption or delay in its formation before birth has a
critical role in the survival of the organism [31–34]. Previously we
reported that a perturbation of Cldn6 expression levels at its
endogenous site of expression - the suprabasal layer of the
epidermis - alters epidermal development and the formation of the
EPB [15,16]. However, depending on whether normal or mutant
forms of Cldn6 are expressed and at what levels, the severity of
phenotypic anomalies varies markedly [15–17,19]. For example,
perinatal lethality resulting from a severely compromised epider-
mal differentiation program and dysfunctional EPB results when
native Cldn6 is expressed at high levels [16]; while with lower
levels of expression, less severe defects occur with the capacity for
normalization of EPB function [15]. In contrast, apparently
normal prenatal epidermal development and formation of a
functioning EPB, but an abnormal postnatal lifelong keratinocyte
hyperproliferation leading to progressive thickening of the
epidermis - but no dermatitis, results when a mutant form of
Cldn6 lacking its entire tail domain (Inv-Cldn6-CD187) is
expressed [17]. On the other hand, high overexpression of a
different mutant lacking only the C-terminal half of the tail
domain of Cldn6 (Inv-Cldn6-CD196) results in a lethal barrier
dysfunction with marked hyperproliferative squamous invagina-
tions/cysts replacing hair follicles [19]. We now show that in Inv-
Cldn6-CD196 mice with lower levels of transgene expression the
abnormalities are much more subtle, and manifested by a slower
than usual (i.e., 1 month versus 2 week) but otherwise apparently
normal maturation of the epidermis from the multilayered
structure seen at birth to the thinner 2–3 cell layer mature
structure [15]. These early postnatal changes in maturation are
not accompanied by abnormalities in the formation of a functional
skin barrier. It is interesting to note that K6- and K17-positive
suprabasal cells, which are normally not present in the mature
epidermis except in situations of abnormal cell proliferation and
differentiation [25–27], are not detectable in the interfollicular
epidermis of either the juvenile or aged Inv-Cldn6-CD196
transgenic samples, until patent dermatitis is evident (see below).
Phenotypic differences observed in the different transgenic mice
appear to reflect different mechanistic consequences of expression
of native or mutant Cldn6. Structure-function details of different
Cldns are only beginning to emerge, but the COOH-terminal tail
varies considerably in length and is the region with the most
Figure 7. Aging-associated barrier dysfunction. Upon gross
observation, obvious signs of dermatitis were evident in aging Inv-
Cldn6-CD196 transgenic mice, especially in areas subjected to repetitive
mechanical stress such as the neck and behind the ears (A). Histological
evaluation revealed a significantly thickened epidermis with an
increased number of spinous/suprabasal cell layers and cellular
disorganization; the upper differentiation layers were also abnormal,
with parakeratosis, the prevalent appearance of nuclei, an improperly
packed granular layer and a thicker stratum corneum (B). TEWL
measurements across the dermatitis-affected transgenic skin confirmed
an approximately 8-fold increase in water loss and a barrier deficient
phenotype (C).
doi:10.1371/journal.pone.0007814.g007
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contains a PDZ-binding motif that enables Cldns to directly interact
with the TJ-associated MAGUKs (ZO-1, ZO-2, and ZO-3) as well
as with MUPP1 and PATJ [35–38]. For at least some Cldns (e.g.,
1 and 5), the cytoplasmic tail upstream of the PDZ-binding motif is
thought to be required for targeting to the TJ complex [39] and
contributes to protein stability [17,40]. Post-translational modifica-
tions within the tail domain, including phosphorylation and
palmitoylation, are also thought to regulate Cldn activities,
including their targeting to the membrane and insertion into TJs
[41], but to date most Cldns have not been subjected to exhaustive
analysis. Thus, the similarities and differences between Inv-Cldn6-
CD187 and Inv-Cldn6-CD196 mice are of interest. Our data
suggest that the phenotype observed in the Inv-Cldn6-CD187
epidermis reflects protein instability and an unfolding protein
response. On the other hand, the delayed maturation and age-
related deficit in wound healing and repair in the Inv-Cldn6-CD196
epidermis most likely involves an aberrant interaction with the
cytoskeleton. Although to date no direct interaction between the
cytoplasmic tail of Cldns and cytoskeletal molecules has been
shown, the possibility of such direct interactions is not unlikely
considering the known roleof the actin cytoskeleton, for example, in
cell shape and cell polarity [42–44].
Despite the importance of the skin barrier to the survival of the
mammalian species, the molecular mechanisms governing its
formation and maintenance are not well-understood, nor are the
changes that occur during the intrinsic aging process of the skin. In
humans, aging-related changes in the skin are widespread and
result from both intrinsic (gene mutations, hormonal changes,
cellular metabolism) and extrinsic (UV exposure, chemicals,
pollutants) factors. While extrinsic factors affect mainly the dermis,
the epidermis is the main target of intrinsic skin aging processes
where, especially in sun-exposed skin, changes occur often with
initial generalized epidermal thickening, indicative of epidermal
hyperplasia and reduced capacity to repair, such that the
epidermis becomes prone to a number of skin conditions including
dermatitis, eczema and ulceration [6,7,45–49]. Only recently has
it been appreciated that abnormal skin barrier function might
underlie these skin conditions [50], although no analysis of Cldn
expression has been reported. The murine epidermis, however,
does not normally undergo comparable aging-related changes; in
fact, once the mouse epidermis is matured it maintains a
homeostatic balance and undergoes morphological and biochem-
ical changes only in response to injury or disease. Thus, it was
extremely interesting to note that in spite of the fact that Inv-
Cldn6-CD196 mice achieve a normal-appearing epidermis by one-
month of age (by morphology and biochemical markers), with
aging they have a high propensity for epidermal injury and a
diminished ability to repair lesions, leading eventually to severe
dermatitis with associated changes in skin barrier function. It
should be noted that this sensitivity to injury and inefficient repair
were seen also in young mice subjected to acute injury by
application of the irritant TPA (data not shown).
As already indicated, the precise mechanisms by which
expression of low levels of Cldn6-CD196 in the suprabasal layers
of the epidermis leads to age-related changes appearing to mimic
those seen in humans are currently not known, but our observations
suggest that changes in Cldn homeostasis leading to changes in the
epidermal differentiation program play important roles. In this
regard, not only changes elicited directly by changes in Cldn6
signaling but also changes imparted by alterations in the expression
of other Cldns, notably Cldn1, must be considered. In the
developing epidermis, Cldn1 is first restricted to the stratifying
layers and matures to occupy the basal layer uponthe completion of
barrier formation at E17.5 [19]. However, in response to TPA-
induced injury and loss of cell polarity seen in tumorigenesis, Cldn1
expression is downregulated in both the basal layer and immediate
suprabasal layers of the epidermis [23,51], alterations seen also with
aging of the Inv-Cldn6-CD196 epidermis. The drastic changes in
TEWL that we observed in severely affected areas of the Inv-Cldn6-
CD196 epidermis also appear to mimic those seen in the aging
human epidermis subjected to stress or injury [47]. Thus the data
reported here suggest that the changes in Cldn expression and
localization in mice with low expression of Cldn6-CD196 in the
epidermis lead to relatively subtle changes in the epidermal
differentiation program and permeability in the young animal,
but render them prone to injury and diminished repair that are
exacerbated especially in areas subjected to repeated mechanical
trauma, leading to chronic and increasingly severe dermatitis.
In summary, our data add to the evidence that Cldn6, and in
particular the C-terminal half of the Cldn6 tail, contribute to the
regulation of epidermal differentiation and skin barrier function
throughout life. They also support the utility of the Inv-Cldn6-
CD196 mouse model for studies aimed at understanding intrinsic
changes in the aging epidermis and point towards a need to
investigate Cldn expression profiles in the aging human epidermis.
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